Neoadjuvant chemotherapy has become popular, especially for patients with advanced
breast cancer. The pros and cons of neoadjuvant chemotherapy for treating breast cancer …

Despite proven benefits of neoadjuvant chemotherapy in patients with locally advanced,
invasive breast cancer, no regimen is recommended as the treatment of choice …

BACKGROUND: Neoadjuvant (primary) chemotherapy is being used increasingly in the
treatment of patients with large and locally advanced breast cancer with the aim of reducing …

A consensus conference regarding the role of neoadjuvant chemotherapy in patients with
carcinoma of the breast was held in April 2003 in Philadelphia to review the evidence in …

Neoadjuvant chemotherapy has several appealing potential benefits compared with classic
adjuvant chemotherapy. Of these, the only proven benefit is to facilitate the surgical …

Primary or neoadjuvant chemotherapy in early breast cancer offers the chance to use the
tumour as an in vivo measure of response, with the additional possibility of down-staging …

BACKGROUND: The aim of this study was to determine outcomes in patients with breast
cancer treated with neoadjuvant chemotherapy. METHODS: Seventy-two consecutive …

Introduction Neoadjuvant chemotherapy in breast cancer is used to downstage locally
advanced and inoperable tumors. Expanded benefits of neoadjuvant chemotherapy include …

The role of neoadjuvant chemotherapy in locally advanced breast cancer is firmly
established. There is now also an emerging role for neoadjuvant systemic therapy in the …

Preoperative or neoadjuvant chemotherapy is an option in patients with early-stage breast
cancer. Neoadjuvant treatment has been compared with standard, postoperative adjuvant …